DOT1L INHIBITORS AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15502623

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to methods of treating AML, associated with DNMT3A mutations by administering one or more DOT1L inhibitors or related pharmaceutical compositions to subjects in need thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYLOR COLLEGE OF MEDICINEONE BAYLOR PLAZA HOUSTON TX 77030

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goodell, Margaret A Houston, US 4 3
Rau, Rachel Houston, US 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation